Skip to content
MedsAcross

Medicine

Potassium citrate 15 mEq extended-release tablet

Available on requestPrescription onlyUS FDAGeneric name

Potassium citrate 15 mEq extended-release tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted at 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Potassium citrate
Brand
Sold under the generic name
Strength
15 mEq
Dosage form
Extended-release tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 18 more
Manufacturers
Zydus LifesciencesIndiaCamber PharmaceuticalsIndiaBryant Ranch PrepackActavis PharmaANI PharmaceuticalsGolden State Medical SupplyXLCare Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted at 15° to 30°C (59° to 86°F). Store in a tight container.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A12BA02 Potassium citrate
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
6 August 2014
Identifiers
RxCUI 898490, 199376, 199381DailyMed set ID 6271d84e-d991-4bb8-ac9f-6d5cc879b631, f2ab3c2e-2a6e-4698-afad-260bdf0d259e, 012c925e-5874-472b-a675-00bf79f64980 +8NDC 72162-1759, 63629-1967, 72162-2121 +8Application ANDA212779, ANDA214420, ANDA203546 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, extended release in 1 bottle65841-538-01Zydus LifesciencesIndia12 August 2014
500 tablet, extended release in 1 bottle65841-538-05Zydus LifesciencesIndia12 August 2014
30 tablet, extended release in 1 bottle65841-538-06Zydus LifesciencesIndia12 August 2014
1000 tablet, extended release in 1 bottle65841-538-10Zydus LifesciencesIndia12 August 2014
90 tablet, extended release in 1 bottle65841-538-16Zydus LifesciencesIndia12 August 2014
10 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack65841-538-30Zydus LifesciencesIndia12 August 2014
100 tablet, extended release in 1 bottle68382-538-01Zydus LifesciencesIndia12 August 2014
500 tablet, extended release in 1 bottle68382-538-05Zydus LifesciencesIndia12 August 2014
30 tablet, extended release in 1 bottle68382-538-06Zydus LifesciencesIndia12 August 2014
1000 tablet, extended release in 1 bottle68382-538-10Zydus LifesciencesIndia12 August 2014
90 tablet, extended release in 1 bottle68382-538-16Zydus LifesciencesIndia12 August 2014
10 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack68382-538-30Zydus LifesciencesIndia12 August 2014
100 tablet, extended release in 1 bottle31722-132-01Camber PharmaceuticalsIndia15 February 2021
100 tablet, extended release in 1 bottle0591-2742-01Actavis Pharma30 May 2018
100 tablet, extended release in 1 bottle62559-292-01ANI Pharmaceuticals16 March 2020
100 tablet, extended release in 1 bottle72865-193-01XLCare Pharmaceuticals25 February 2021
100 tablet, extended release in 1 bottle63629-1967-1Bryant Ranch Prepack8 February 2022
100 tablet, extended release in 1 bottle71335-2897-1Bryant Ranch Prepack23 October 2025
100 tablet, extended release in 1 bottle72162-1759-1Bryant Ranch Prepack25 March 2026
100 tablet, extended release in 1 bottle72162-2121-1Bryant Ranch Prepack18 September 2023
100 tablet, extended release in 1 bottle51407-451-01Golden State Medical Supply23 August 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 August 1985Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Potassium citrate 15 mEq extended-release tablet.

Compare 1

Other strengths and forms of Potassium citrate

Clinical summary

Potassium citrate is an anti-coagulant indicated for the management of renal tubular acidosis, among other approved uses. It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Potassium citrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Potassium citrate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Potassium citrate 15 mEq extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.